Suppr超能文献

用于治疗酒精使用障碍的最先进的行为和药理学疗法。

State-of-the-art behavioral and pharmacological treatments for alcohol use disorder.

机构信息

a Department of Psychology , University of California , Los Angeles , CA , USA.

b Department of Psychiatry and Biobehavioral Sciences, UCLA School of Medicine University of California , Los Angeles , CA , USA.

出版信息

Am J Drug Alcohol Abuse. 2019;45(2):124-140. doi: 10.1080/00952990.2018.1528265. Epub 2018 Oct 29.

Abstract

BACKGROUND

Alcohol use disorder (AUD) and its associated consequences remain significant public health concerns. Given that AUD represents a spectrum of severity, treatment options represent a continuum of care, ranging from single-session brief interventions to more intensive, prolonged, and specialized treatment modalities.

OBJECTIVE

This qualitative literature review seeks to describe the best practices for AUD by placing a particular emphasis on identifying those practices which have received the most empirical support.

METHOD

This review summarizes psychological and pharmacological intervention options for AUD treatment, with a focus on the relapse prevention phase of recovery. Psychological and pharmacological treatments are summarized in terms of the empirical evidence favoring each approach and the level of AUD severity for which they are most indicated.

SCIENTIFIC SIGNIFICANCE

One of the broad assertions from this review is that while AUD is highly prevalent, seeking treatment for AUD is not. There are a myriad of behavioral and pharmacological treatments that have shown compelling evidence of efficacy for the treatment of AUD. In the behavioral treatment literature, cognitive behavioral therapy has received the most consistent support. Opioid antagonism (via naltrexone) has been the most widely studied pharmacotherapy and has produced moderate effect sizes. While none of the treatments reviewed herein represents a so-called silver bullet for AUD, they each have the potential to significantly improve the odds of recovery. Precision medicine, or the identification of best treatment matches for individual patients, looms as an important overarching goal for the field, although specific matches are not yet sufficiently reliable in their empirical evidence to warrant clinical dissemination.

摘要

背景

酒精使用障碍(AUD)及其相关后果仍然是重大的公共卫生问题。鉴于 AUD 代表了严重程度的连续谱,治疗选择代表了连续的护理范围,从单次短暂干预到更密集、更持久和专门的治疗模式。

目的

本定性文献综述旨在描述 AUD 的最佳实践,特别强调确定那些得到最多经验支持的实践。

方法

本综述总结了 AUD 治疗的心理和药理学干预选择,重点是康复的复发预防阶段。根据每种方法的实证证据和最适合的 AUD 严重程度,对心理和药理学治疗进行了总结。

科学意义

从本次综述中得出的一个广泛主张是,尽管 AUD 非常普遍,但寻求 AUD 治疗的人并不多。有许多行为和药理学治疗方法已经证明对 AUD 治疗具有令人信服的疗效。在行为治疗文献中,认知行为疗法得到了最一致的支持。阿片类拮抗剂(纳曲酮)是研究最多的药物治疗方法,产生了中等的效果大小。虽然本文综述中没有一种治疗方法被称为 AUD 的所谓银弹,但它们都有可能显著提高康复的几率。精准医学,或为个体患者确定最佳治疗匹配,是该领域的一个重要总体目标,尽管特定的匹配在其经验证据中还不够可靠,无法保证临床推广。

相似文献

1
State-of-the-art behavioral and pharmacological treatments for alcohol use disorder.
Am J Drug Alcohol Abuse. 2019;45(2):124-140. doi: 10.1080/00952990.2018.1528265. Epub 2018 Oct 29.
2
Treatment of Alcohol Use Disorder: Behavioral and Pharmacologic Therapies.
Clin Liver Dis. 2024 Nov;28(4):761-778. doi: 10.1016/j.cld.2024.06.011.
4
Overview of Alcohol Use Disorder.
Am J Psychiatry. 2023 Aug 1;180(8):565-572. doi: 10.1176/appi.ajp.20230488.
5
Novel Agents for the Pharmacological Treatment of Alcohol Use Disorder.
Drugs. 2022 Feb;82(3):251-274. doi: 10.1007/s40265-021-01670-3. Epub 2022 Feb 8.
6
Opioid antagonists for pharmacological treatment of alcohol dependence - a critical review.
Curr Drug Abuse Rev. 2008 Nov;1(3):280-91. doi: 10.2174/1874473710801030280.
7
Emerging approaches to managing alcohol dependence.
Am J Health Syst Pharm. 2007 Mar 1;64(5 Suppl 3):S12-22. doi: 10.2146/ajhp060644.
8
Potential medications for the treatment of alcohol use disorder: An evaluation of clinical efficacy and safety.
Subst Abus. 2016 Apr-Jun;37(2):286-98. doi: 10.1080/08897077.2015.1133472.

引用本文的文献

1
2
Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs): A Pan-Steatotic Liver Disease Treatment?
Biomedicines. 2025 Jun 20;13(7):1516. doi: 10.3390/biomedicines13071516.
4
Investigating Therapeutic Targets for Alcohol Use Disorder: Pharmacological View of ClinicalTrials.gov Data.
Int J Gen Med. 2025 Jul 4;18:3701-3712. doi: 10.2147/IJGM.S530721. eCollection 2025.
6
Changes in neurobiological markers of reactivity to alcohol-related stimuli in alcohol-dependent patients after two years of treatment.
Front Psychiatry. 2025 Jun 18;16:1613169. doi: 10.3389/fpsyt.2025.1613169. eCollection 2025.
7
GRIK1 genotype and effect of topiramate for alcohol use: a systematic review.
J Pharm Health Care Sci. 2025 May 20;11(1):42. doi: 10.1186/s40780-025-00449-y.

本文引用的文献

1
Baclofen: its effectiveness in reducing harmful drinking, craving, and negative mood. A meta-analysis.
Addiction. 2018 Aug;113(8):1396-1406. doi: 10.1111/add.14191. Epub 2018 Mar 24.
3
Precision Medicine in Alcohol Dependence: A Controlled Trial Testing Pharmacotherapy Response Among Reward and Relief Drinking Phenotypes.
Neuropsychopharmacology. 2018 Mar;43(4):891-899. doi: 10.1038/npp.2017.282. Epub 2017 Nov 20.
4
Cognitive behavioral interventions for alcohol and drug use disorders: Through the stage model and back again.
Psychol Addict Behav. 2017 Dec;31(8):847-861. doi: 10.1037/adb0000311. Epub 2017 Aug 31.
6
Cue exposure therapy for the treatment of alcohol use disorders: A meta-analytic review.
Clin Psychol Rev. 2017 Nov;57:195-207. doi: 10.1016/j.cpr.2017.07.006. Epub 2017 Jul 27.
7
Precision medicine and pharmacogenetics: what does oncology have that addiction medicine does not?
Addiction. 2017 Dec;112(12):2086-2094. doi: 10.1111/add.13818. Epub 2017 Apr 21.
8
Differences between treatment-seeking and non-treatment-seeking participants in medication studies for alcoholism: do they matter?
Am J Drug Alcohol Abuse. 2017 Nov;43(6):703-710. doi: 10.1080/00952990.2017.1312423. Epub 2017 Apr 20.
9
Mindfulness treatment for substance misuse: A systematic review and meta-analysis.
J Subst Abuse Treat. 2017 Apr;75:62-96. doi: 10.1016/j.jsat.2017.01.008. Epub 2017 Jan 31.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验